Sestre Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $666K

  • Investors
  • 7

Sestre General Information

Description

Provider of nutraceutical supplements intended to fight hormonal problems that have an impact on female fertility. The company's supplements are based on the study of chronic diseases and hormonal dysfunctions for which there are currently no effective therapeutic services available through specific product formulations, enabling customers to improve their quality of life by helping pregnant women during the research stage of pregnancy.

Contact Information

Website
www.sestre.it
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Oberdan number 9
  • 76015 Trinitapoli(Barletta-Andria-Trani)
  • Italy
+39 0883
Primary Industry
Other Consumer Non-Durables
Corporate Office
  • Via Oberdan number 9
  • 76015 Trinitapoli(Barletta-Andria-Trani)
  • Italy
+39 0883

Sestre Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sestre Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 25-Sep-2024 $666K Completed Generating Revenue
8. Accelerator/Incubator 20-Jul-2023 Completed Generating Revenue
7. Seed Round Cancelled Generating Revenue
6. Accelerator/Incubator 28-Jun-2022 Completed Generating Revenue
5. Grant 01-Jan-2022 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
3. Grant 01-Jan-2020 Completed Startup
2. Grant 01-Jan-2019 $7.97K $47.8K Completed Startup
1. Capitalization 01-Jan-2019 $47.8K $47.8K Completed Startup
To view Sestre’s complete valuation and funding history, request access »

Sestre Patents

Sestre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4694879-A1 Composition for oral use comprising quercetin and bromelain Pending 11-Apr-2023
WO-2024213970-A1 Composition for oral use comprising quercetin and bromelain Inactive 11-Apr-2023

Sestre Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sestre Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cassa Depositi e Prestiti Corporation Minority
UniCredit Start Lab Accelerator/Incubator
Terra Next Accelerator Accelerator/Incubator Minority
Sistema Puglia Government
EIT Food Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Sestre FAQs

  • When was Sestre founded?

    Sestre was founded in 2019.

  • Where is Sestre headquartered?

    Sestre is headquartered in Trinitapoli, Italy.

  • What is the size of Sestre?

    Sestre has 8 total employees.

  • What industry is Sestre in?

    Sestre’s primary industry is Other Consumer Non-Durables.

  • Is Sestre a private or public company?

    Sestre is a Private company.

  • What is Sestre’s current revenue?

    The current revenue for Sestre is .

  • How much funding has Sestre raised over time?

    Sestre has raised $798K.

  • Who are Sestre’s investors?

    Cassa Depositi e Prestiti, UniCredit Start Lab, Terra Next Accelerator, Sistema Puglia, and EIT Food are 5 of 7 investors who have invested in Sestre.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process